- Home
- SYRE vs FBRT Comparison
SYRE vs FBRT Comparison
Compare SYRE & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- FBRT
- Stock Information
- Founded
- SYRE 2013
- FBRT 2012
- Country
- SYRE United States
- FBRT United States
- Employees
- SYRE N/A
- FBRT N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- FBRT Real Estate Investment Trusts
- Sector
- SYRE Health Care
- FBRT Real Estate
- Exchange
- SYRE Nasdaq
- FBRT Nasdaq
- Market Cap
- SYRE 1.1B
- FBRT 918.2M
- IPO Year
- SYRE 2016
- FBRT 1985
- Fundamental
- Price
- SYRE $17.38
- FBRT $11.34
- Analyst Decision
- SYRE Buy
- FBRT Strong Buy
- Analyst Count
- SYRE 5
- FBRT 5
- Target Price
- SYRE $55.00
- FBRT $14.90
- AVG Volume (30 Days)
- SYRE 490.8K
- FBRT 633.9K
- Earning Date
- SYRE 08-05-2025
- FBRT 07-30-2025
- Dividend Yield
- SYRE N/A
- FBRT 12.54%
- EPS Growth
- SYRE N/A
- FBRT 18.52
- EPS
- SYRE N/A
- FBRT 0.98
- Revenue
- SYRE N/A
- FBRT $207,768,000.00
- Revenue This Year
- SYRE N/A
- FBRT $28.21
- Revenue Next Year
- SYRE N/A
- FBRT $2.40
- P/E Ratio
- SYRE N/A
- FBRT $11.55
- Revenue Growth
- SYRE N/A
- FBRT 16.05
- 52 Week Low
- SYRE $10.91
- FBRT $9.79
- 52 Week High
- SYRE $40.26
- FBRT $13.74
- Technical
- Relative Strength Index (RSI)
- SYRE 57.01
- FBRT 63.22
- Support Level
- SYRE $15.73
- FBRT $11.02
- Resistance Level
- SYRE $17.42
- FBRT $11.25
- Average True Range (ATR)
- SYRE 0.89
- FBRT 0.16
- MACD
- SYRE 0.07
- FBRT 0.05
- Stochastic Oscillator
- SYRE 86.50
- FBRT 95.31
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.